- Home
- RNAZ vs SPPL Comparison
RNAZ vs SPPL Comparison
Compare RNAZ & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- SPPL
- Stock Information
- Founded
- RNAZ 2016
- SPPL 2016
- Country
- RNAZ United States
- SPPL Singapore
- Employees
- RNAZ N/A
- SPPL N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- SPPL
- Sector
- RNAZ Health Care
- SPPL
- Exchange
- RNAZ Nasdaq
- SPPL Nasdaq
- Market Cap
- RNAZ 8.7M
- SPPL 9.8M
- IPO Year
- RNAZ 2021
- SPPL 2023
- Fundamental
- Price
- RNAZ $13.77
- SPPL $5.67
- Analyst Decision
- RNAZ Strong Buy
- SPPL
- Analyst Count
- RNAZ 1
- SPPL 0
- Target Price
- RNAZ $280.00
- SPPL N/A
- AVG Volume (30 Days)
- RNAZ 421.5K
- SPPL 10.3K
- Earning Date
- RNAZ 11-13-2025
- SPPL 01-01-0001
- Dividend Yield
- RNAZ N/A
- SPPL N/A
- EPS Growth
- RNAZ N/A
- SPPL N/A
- EPS
- RNAZ N/A
- SPPL N/A
- Revenue
- RNAZ N/A
- SPPL $4,591,508.00
- Revenue This Year
- RNAZ N/A
- SPPL N/A
- Revenue Next Year
- RNAZ N/A
- SPPL N/A
- P/E Ratio
- RNAZ N/A
- SPPL N/A
- Revenue Growth
- RNAZ N/A
- SPPL 24.27
- 52 Week Low
- RNAZ $6.15
- SPPL $2.16
- 52 Week High
- RNAZ $643.94
- SPPL $16.80
- Technical
- Relative Strength Index (RSI)
- RNAZ 55.86
- SPPL 51.64
- Support Level
- RNAZ $12.11
- SPPL $5.33
- Resistance Level
- RNAZ $15.49
- SPPL $6.20
- Average True Range (ATR)
- RNAZ 1.74
- SPPL 0.39
- MACD
- RNAZ -0.13
- SPPL -0.11
- Stochastic Oscillator
- RNAZ 23.76
- SPPL 20.36
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About SPPL SIMPPLE LTD.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.